BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28465481)

  • 1. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
    Ma K; Cao B; Guo M
    Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas.
    Gyobu K; Yamashita S; Matsuda Y; Igaki H; Niwa T; Oka D; Kushima R; Osugi H; Lee S; Suehiro S; Ushijima T
    Ann Surg Oncol; 2011 Apr; 18(4):1185-94. PubMed ID: 21042947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
    Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
    PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
    Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
    J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.
    Pan QF; Li WT; Dong HC; Chen YZ; Yin L; Liu W; Wang WW; Liu D; Li SG; Gu WY; Chen JZ; Yang L; Zhang WJ; Li F
    Dis Esophagus; 2014; 27(4):396-402. PubMed ID: 23980519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers.
    Talukdar FR; Soares Lima SC; Khoueiry R; Laskar RS; Cuenin C; Sorroche BP; Boisson AC; Abedi-Ardekani B; Carreira C; Menya D; Dzamalala CP; Assefa M; Aseffa A; Miranda-Gonçalves V; Jerónimo C; Henrique RM; Shakeri R; Malekzadeh R; Gasmelseed N; Ellaithi M; Gangane N; Middleton DRS; Le Calvez-Kelm F; Ghantous A; Roux ML; Schüz J; McCormack V; Parker MI; Pinto LFR; Herceg Z
    Cancer Res; 2021 May; 81(10):2612-2624. PubMed ID: 33741694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
    Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
    Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma.
    Teng H; Xue M; Liang J; Wang X; Wang L; Wei W; Li C; Zhang Z; Li Q; Ran X; Shi X; Cai W; Wang W; Gao H; Sun Z
    Theranostics; 2020; 10(7):3035-3048. PubMed ID: 32194853
    [No Abstract]   [Full Text] [Related]  

  • 15. FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Iwabu J; Yamashita S; Takeshima H; Kishino T; Takahashi T; Oda I; Koyanagi K; Igaki H; Tachimori Y; Daiko H; Nakazato H; Nishiyama K; Lee YC; Hanazaki K; Ushijima T
    Sci Rep; 2019 Sep; 9(1):13347. PubMed ID: 31527639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.
    Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z
    Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.
    Roy R; Kandimalla R; Sonohara F; Koike M; Kodera Y; Takahashi N; Yamada Y; Goel A
    Int J Cancer; 2019 Mar; 144(5):1160-1169. PubMed ID: 30006931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.
    Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T
    Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.